RFCL Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

  • Investments
  • 3

RFCL General Information

Description

Provider of vitro diagnostics, animal healthcare, custom synthesis, and laboratory solutions. The company offers products for diabetes, hematology, infectious diseases, women healthcare, and routine chemistry; and laboratory reagents, imported chemicals, filtration and chromatography products, certified reference standards, liquid handling, and biopharmaceutical products.

Contact Information

Website
www.rfcl.in
Formerly Known As
Ranbaxy Fine Chemicals Limited
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • A-Three, Okhla Industrial Area
  • Phase One
  • New Delhi, 110020
  • India
+91 011
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • A-Three, Okhla Industrial Area
  • Phase One
  • New Delhi, 110020
  • India
+91 011

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RFCL Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore RFCL‘s full profile, request access.

Request a free trial

RFCL Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore RFCL‘s full profile, request access.

Request a free trial

RFCL Investments (3)

RFCL’s most recent deal was a Buyout/LBO with Bremer Pharma. The deal was made on 31-Mar-2008.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Bremer Pharma 31-Mar-2008 Buyout/LBO Other Commercial Products
Wipro Biomed 24-Jul-2007 Buyout/LBO BPO/Outsource Services
Vetnex Animal Health Buyout/LBO Other Agriculture
To view RFCL’s complete investments history, request access »

RFCL Exits (2)

RFCL’s most recent exit was on 31-Mar-2008 from Bremer Pharma. The exit was categorized as with 3 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Bremer Pharma 31-Mar-2008 Completed
  • 3 buyers
Vetnex Animal Health Buyout/LBO Completed
  • 2 buyers
To view RFCL’s complete exits history, request access »

RFCL FAQs

  • When was RFCL founded?

    RFCL was founded in 2005.

  • Where is RFCL headquartered?

    RFCL is headquartered in New Delhi, India.

  • What industry is RFCL in?

    RFCL’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is RFCL a private or public company?

    RFCL is a Private company.

  • What is the current valuation of RFCL?

    The current valuation of RFCL is .

  • What is RFCL’s current revenue?

    The current revenue for RFCL is .

  • Who are RFCL’s investors?

    ICICI Venture has invested in RFCL.

  • When was RFCL acquired?

    RFCL was acquired on 04-Nov-2010.

  • Who acquired RFCL?

    RFCL was acquired by Avantor.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process